We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has given Takeda’s Ninlaro the green light of approval in combination with other therapies to treat multiple myeloma in the second-line setting. Read More
Industry groups are rushing to the aid of Pacira Pharmaceuticals in its ongoing legal battle with the FDA over promotional claims, asking the courts to side with the drugmaker. Read More
The National Health Service of England and the National Institute for Health and Care Excellence have unveiled a proposal that could provide a new pathway for innovative drugs to be assessed and made available to patients. Read More
A Texas drug compounder is recalling all lots of its sterile drug products after an FDA inspection found it had not investigated failed sterility tests. Read More
The European Commission released new rules clarifying the responsibilities of qualified persons overseeing global, multisite manufacturing operations and the data they need to collect. Read More
The National Institute for Health and Care Excellence has given the green light to Bayer’s Xofigo in England and Wales as an option for treating adults with hormone-relapsed prostate cancer, symptomatic bone metastases and no known visceral metastases, albeit with restrictions. Read More